CTRI/2018/05/013614招募中2 期
A Double Blind Placebo Controlled Clinical Study to Evaluate Efficacy and Safety of Emotional discouragement capsules in Individuals presenting with mild occasional emotional discouragement - EmoDc
试验速览
- 阶段
- 2 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female subjects with aged between 18-60 years.
- •2.Individual presenting with atleast one of the symptoms like occasional emotional discouragement, occasional /mild Stress/ irritability/ Short temper/Anger and Frustration.
- •3.Subjects willing to sign informed consent and follow the study procedure.
- •4.Has not participated in a similar investigation in the past four weeks.
排除标准
- •1.Those with serious cardiovascular, cerebrovascular, respiratory, liver or renal disease or any other disorder
- •2.The subjects who have used any drugs, for at least 1 week prior to the study
- •3.Subjects with a strong history of food or drug allergy of any kind
- •4.Individuals unwilling to provide informed consent or abide by the requirements of the study
研究者
相似试验
尚未招募
4 期
Clinical study to evaluate a polyherbal product in individuals with compromised alertness, energy, concentration, and behavioral integrity due to suboptimal Sleep Quality.CTRI/2022/09/045604Amway Global Services India Pvt Ltd
已完成
不适用
A study to find the difference in bioavailability of 3 different ingredients through FenuMAT delivery system and its comparison with natural existing forms.CTRI/2018/03/012753Akay Flavours and Aromatics Private Limited45
已完成
不适用
A study to find the increase in bioavailability of 2 different ingredients through FenuMAT delivery system and its comparison with natural existing forms.CTRI/2018/03/012875Akay Flavours and Aromatics Private Limited30
已完成
2 期
A double blind placebo controlled clinical trial to evaluate the efficacy and safety of Shatavari in Menstrual irregularityCTRI/2011/06/001804The Himalaya Drug Company50
已完成
2 期
A Randomized Double Blind Placebo Controlled Study Of Celecoxib Add-On In Obsessive Compulsive DisorderCTRI/2022/01/039407King George Medical University44